Literature DB >> 2815158

Novel steroidal pure antiestrogens.

J Bowler1, T J Lilley, J D Pittam, A E Wakeling.   

Abstract

A series of steroidal estrogen antagonists with no intrinsic estrogenicity in rat uterotrophic-antiuterotrophic tests has been discovered. The compounds are derivatives of estradiol containing amidoalkyl side chains at the 7 alpha-position. The most potent compounds are N-n-butyl-N-methyl-11-(3,17 beta-dihydroxyestra- 1,3,5(10)-trien-7 alpha-yl) undecanamide and N-2,2,3,3,4,4,4-heptafluorobutyl-N-methyl-11-(3,17 beta-dihydroxyestra- 1,3,5(10)-trien-7 alpha-yl) undecanamide. Structure activity relationships are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2815158     DOI: 10.1016/0039-128x(89)90076-7

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  24 in total

1.  New chemical syntheses of cholest-4,6-dien-3-one.

Authors:  Edward J Parish; Hang Sun; Ding Lu; Stephen A Kizito; Zhihai Qiu
Journal:  Lipids       Date:  2002-12       Impact factor: 1.880

2.  Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro.

Authors:  N D Arbuckle; S Dauvois; M G Parker
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

3.  Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.

Authors:  S Dauvois; P S Danielian; R White; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.

Authors:  S E Fawell; R White; S Hoare; M Sydenham; M Page; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain.

Authors:  Abhishek Sharma; Weiyi Toy; Valeria Sanabria Guillen; Naina Sharma; Jian Min; Kathryn E Carlson; Christopher G Mayne; Shengjia Lin; Michael Sabio; Geoffrey Greene; Benita S Katzenellenbogen; Sarat Chandarlapaty; John A Katzenellenbogen
Journal:  ACS Chem Biol       Date:  2018-11-26       Impact factor: 5.100

Review 6.  Transcription factors as drug targets: opportunities for therapeutic selectivity.

Authors:  T R Butt; S K Karathanasis
Journal:  Gene Expr       Date:  1995

7.  Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents.

Authors:  Zhongliang Wan; Musiliyu A Musa; Patrick Joseph; John S Cooperwood
Journal:  Mini Rev Med Chem       Date:  2013-07       Impact factor: 3.862

8.  Convergent synthesis of a deuterium-labeled serine dipeptide lipid for analysis of biological samples.

Authors:  Christopher Dietz; Robert B Clark; Frank C Nichols; Michael B Smith
Journal:  J Labelled Comp Radiopharm       Date:  2017-04-16       Impact factor: 1.921

9.  Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.

Authors:  A Mahfoudi; E Roulet; S Dauvois; M G Parker; W Wahli
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity.

Authors:  Xiang-Rong Jiang; Pan Wang; Carolyn L Smith; Bao Ting Zhu
Journal:  J Med Chem       Date:  2013-03-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.